Page results
-
There are now seven patients participating in the GB-PRIME study involving Neuralink’s brain-computer interface (BCI) technology, which aims to improve independence for people who are paralysed.
-
Here you will find more information on our publications.
-
This page is for parents, carers and relatives whose child is having radiotherapy treatment to the eye (orbit). There are different conditions that may require radiotherapy to the eye such as retinoblastoma, orbital rhabdomyosarcomas, soft tissue sarcomas, lymphomas, or some other condition.
-
Adding the hormone therapy abiraterone to the standard treatment for locally advanced prostate cancer, where the cancer has a high chance of spreading, could halve the risk of death, according to the results of a trial at UCLH and UCL.
-
UCLH will transition to a new Laboratory Information Management System (LIMS) for Blood Science disciplines’ (Biochemistry, Immunology, Haematology, Coagulation and Virology) testing. The new platform is known as ‘Helix’. This is a change to the laboratory system only, as such there should be no change to GP users in requesting or receiving reports.
-
Medtronic have informed us that there is a potential issue relating to the battery cap on some Medtronic insulin pumps (including 640, 670 and 780 series pumps).
-
UCLH cancer services including radiotherapy has been awarded the PIF TICK – the UK’s only assessed quality mark for print and online health and care information.
-
An online exhibition by Dr Sarah Yardley and artist Daniel Regan, exploring the role of relationships and relationship-centred approaches to healthcare.
-
This week, clinical leaders across north central London have written to our local newspapers, outlining the rationale for temporary changes to children and young people's services across the region. The letter reflects on some of the lessons learnt from the first wave of the COVID-19 pandemic and the need to plan ahead for a likely second surge and a busy winter with all of the challenges that will bring. You can read the letter in full here:
-
Anyone can develop oesophageal cancer, however there are factors that can increase the risk. Watch our series of videos and find out what oesophageal cancer is, the signs and symptoms and learn how it can be diagnosed and treated.
File results
-
FOI/2023/0665 - Trust pathology services
-
FOI/2023/0670 - Treatment with immunomodulatory medications
-
FOI/2023/0672 - Treatment with dermatology and respiratory medicine
-
FOI/2023/0675 - Number of cancer treatments at each stage
-
FOI/2023/0681 - Patient friends and family test supplier
-
FOI/2023/0683 - Electronic Patient Records (EPR)/ Patient Administration System (PAS)
-
FOI/2023/0686 - Hysteroscopy Inpatient and Outpatient pathways
-
FOI/2023/0687 - Information Governance pay grades
-
FOI/2023/0689 - Access to digital test results for patients
-
FOI/2023/0691 - Integrated medicine